Default: Journal of Thoracic Oncology

ISSN: 1556-0864

Journal Home

Journal Guideline

Journal of Thoracic Oncology Q1 Unclaimed

International Association for the Study of Lung Cancer United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Thoracic Oncology is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 123. It has an SJR impact factor of 3,218 and it has a best quartile of Q1.

Type: Journal

Type of Copyright:


Open Access Policy:

Type of publications:

Publication frecuency: -


- €

Gold OA


Green OA

- €

Non OA


Journal of Thoracic Oncology


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)



Best articles

191TiP: MYSTIC: a global, phase 3 study of durvalumab (MEDI4736) plus tremelimumab combination therapy or durvalumab monotherapy versus platinum-based chemotherapy (CT) in the first-line treatment of patients (pts) with advanced stage IV NSCLC

View more

68P In vivo study of a novel chemoablative, thermoresponsive hydrogel for intratumoural administration in a murine A549 xenograft model

View more

A Phase III Randomized Trial of Gemcitabine-Oxaliplatin versus Carboplatin-Paclitaxel as First-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer

View more

Acetylcholine Receptor Pathway and Lung Cancer

View more

Adjuvant Chemotherapy Uptake in Non-small Cell Lung Cancer

View more

Alpha-Actinin 4 Is Associated with Cancer Cell Motility and Is a Potential Biomarker in Non-Small Cell Lung Cancer

View more

Alpha1-Antitrypsin Deficiency Carriers, Serum Alpha 1-Antitrypsin Concentration, and Non-small Cell Lung Cancer Survival

View more

Best of the Month: A Round Up of Articles Published in Recent Months

View more

Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges

View more

Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium

View more

BRMS1 Expression in Surgically Resected Lung Adenocarcinoma Predicts Future Metastases and Is Associated with a Poor Prognosis

View more

Cancer Stem Cells and Targeting Embryonic Signaling Pathways

View more

Cell Cycle-Associated Kinases as Targets for Therapy in Lung Cancer

View more

Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical Practice

View more

Chemotherapy in Patients =80 with Advanced Non-small Cell Lung Cancer: Combined Results from SWOG 0027 and LUN 6

View more

Clinical and Testing Protocols for the Analysis of Epidermal Growth Factor Receptor Mutations in East Asian Patients with Non-small Cell Lung Cancer: A Combined Clinical-Molecular Pathological Approach

View more

Clinical Effectiveness of Boron Neutron Capture Therapy for a Recurrent Malignant Peripheral Nerve Sheath Tumor in the Mediastinum

View more

Clinical Utility of Epidermal Growth Factor Receptor Expression for Selecting Patients with Advanced Non-small Cell Lung Cancer for Treatment with Erlotinib

View more

Comparative Effectiveness of Adjunctive Bevacizumab for Advanced Lung Cancer: The Cancer Research Network Experience

View more

Cost-Effectiveness of Follow-Up for Subsolid Pulmonary Nodules in High-Risk Patients

View more

Differences in Longitudinal Health Utility between Stereotactic Body Radiation Therapy and Surgery in Stage I Non-Small Cell Lung Cancer

View more

EML4/ALK and Ras Inhibitors

View more

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for the Diagnosis of Intrapulmonary Lesions

View more

Epidermal Growth Factor Receptor Pathway

View more


No comments ... Be the first to comment!